Janssen Corrects Risperdal "Dear Doctor" Letter
This article was originally published in The Pink Sheet Daily
Executive Summary
The action follows an FDA warning letter in April. Janssen's previous letter to doctors had suggested Risperdal was safer than other atypical antipsychotics.